Detailed Information

Cited 26 time in webofscience Cited 0 time in scopus
Metadata Downloads

BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M+NSCLC: Efficacy and safety at the RP2D.

Authors
Park, KeunchilLee, Jong-SeokLee, Ki HyeongKim, Joo-HangCho, Byoung ChulMin, Young JooCho, Jae YongHan, Ji-YounKim, Bong-SeogKim, Jin-SooLee, Dae HoKang, Jin HyoungCho, Eun KyungKim, Hoon-GuLee, Kyung HeeKim, Hoon KyoJang, In-JinKim, Hyo-YeonSon, JeewoongKim, Dong-Wan
Issue Date
20-May-2016
Publisher
AMER SOC CLINICAL ONCOLOGY
Citation
JOURNAL OF CLINICAL ONCOLOGY, v.34, no.15
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
Volume
34
Number
15
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8283
DOI
10.1200/JCO.2016.34.15_suppl.9055
ISSN
0732-183X
Files in This Item
There are no files associated with this item.
Appears in
Collections
의과대학 > 의학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Cho, Eun Kyung photo

Cho, Eun Kyung
College of Medicine (Department of Medicine)
Read more

Altmetrics

Total Views & Downloads

BROWSE